Search results
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 6 days agoMerck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 2 hours agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 7 days agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
Merck reports data from Phase III gastric cancer treatment trial
Clinical Trials Arena via Yahoo Finance· 6 days agoMerck (MSD) has announced the final analysis findings from the Phase III KEYNOTE-811 clinical trial...
Jemperli contends with blockbuster Keytruda in endometrial cancer
Clinical Trials Arena via Yahoo Finance· 7 days agoThe sBLA approval is based on the success of the Phase III RUBY Part I trial and places Jemperli in...
Here's Why Merck (MRK) is a Strong Momentum Stock
Zacks via Yahoo Finance· 5 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
How mRNA vaccines could be personalized cancer cures
Axios· 21 hours agoAn expanding pipeline of vaccines is giving patients new hope against some of the deadliest cancers, by training the body's immune system to attack...
3 Investing Pros Lay Out Their Dividend Strategies—and Stock Picks
Barrons.com· 6 days agoIn February, Walmart announced a 9% dividend increase, its largest in more than a decade. Another of...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 6 days agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
Calliditas' survival data salvage midphase cancer trial after primary endpoint miss
FierceBiotech· 1 day agoCalliditas Therapeutics had a typical to-do list for its midphase head and neck cancer study. Step...